Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Document Appropriate Indication and Physician Rationale for Antipsychotic Use

Overland Park, Kansas Survey Completed on 06-04-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that two residents with dementia diagnoses received antipsychotic medications only with appropriate indications and documented physician rationale. For one resident with moderately impaired cognition and diagnoses including dementia and Alzheimer's disease, the medical record showed ongoing administration of olanzapine for psychosis without documentation of risk versus benefit or evidence of unsuccessful nonpharmacological interventions. The pharmacy consultant had identified and reported irregularities related to the non-approved indication for this antipsychotic use, but the facility was unable to provide the required physician documentation upon request. For another resident with severely impaired cognition and Alzheimer's disease, quetiapine was administered for severe dementia with agitation. The medical record lacked a physician-documented rationale for the continued use of this antipsychotic for dementia-related behaviors, and no documentation of risk versus benefit was available. The care plan referenced attempts at gradual dose reduction and nonpharmacological interventions, but there was no supporting physician documentation for the ongoing use of the medication. Interviews with nursing staff and administration revealed uncertainty regarding appropriate indications for antipsychotic medications and a lack of awareness about the need for physician documentation of risk versus benefit. The facility's policy required monitoring the need for psychotropic medications and evaluating their effectiveness, but these requirements were not met in the cases reviewed, resulting in the administration of unnecessary psychotropic medications without proper justification.

An unhandled error has occurred. Reload 🗙